Looking after grandchildren on a regular basis could significantly lower your risk of dementia, say scientists
The findings add to a growing body of research that suggests practical and social engagement in older age boosts cognitive health.
1
While there's no guaranteed way to prevent dementia, certain lifestyle changes can significantly reduce your risk.
A new study, published in Jama Network Open, found grandparents who cared for their grandchildren on a frequent but noncustodial basis had a statically significant lower risk of developing dementia, when compared to those who didn't engage in such roles.
Scientists also noted grandparents who were caregiving were more likely to have a mobile phone, which kept them more connected and also helped lower the risk.
The study analysed the experiences of more than 10,000 older adults in China and tracked cognitive outcomes in relation to their caregiving activities.
In China, roughly 17 million people were living with dementia in 2019, according to a report published in JAMA Neurology in February 2020.
"Dementia is a pressing public health concern, with a substantial burden in China, which accounts for nearly 25 per cent of worldwide cases and great socioeconomic costs," the authors wrote.
The findings of the new study support previous research suggesting staying socially active and engaged can help preserve brain health, particularly in elderly adults.
"The protective association of nonintensive caregiving with dementia odds supports the use-it-or-lose-it hypothesis, which posits that engaging in mentally and socially stimulating activities—such as interacting with grandchildren—can preserve cognitive reserves and delay cognitive decline," the researchers concluded.
But the study did caution more intense caregiving duties could have a negative impact.
"These benefits, however, appear to have a threshold, as intensive caregiving, often accompanied by heightened stress and caregiving burden, was not associated with reduced dementia odds," the authors warned.
Five simple tests that could indicate dementia
Social isolation can lead to an increased risk of developing dementia, says the Alzheimer's Society.
This is related to whether a person lives alone, and whether they see friends and family regularly or engage in social or community activities.
As well as staying in touch with loved ones, finding activities or groups that align with your interests, such as book clubs, walking groups, or sports teams, can help maintain social connections.
Embracing new experiences, such as learning new skills or taking up new hobbies can also help.
And finding opportunities to connect, such as being open to meeting new people and forming new connections, may also be beneficial.
Alongside staying socially connected, experts recommend the following lifestyle changes to stave off dementia...
Other ways to reduce your dementia risk
There are a number of things you can do to reduce your risk of developing dementia. Alzheimer's Society offers the following tips:
Do regular physical exercise
Regular physical activity is considered one of the best ways to reduce your risk of dementia. There are two main types - aerobic activity and strength-building activity. Aerobic activity includes activities like brisk walking, running and swimming. Strength-building include exercises like squats and push-ups. A combination of both types of activity is best.
Drink less alcohol
Drinking too much alcohol exposes your brain to high levels of harmful chemicals. You should avoid drinking more than 14 units of alcohol each week. This is the equivalent of one pint of beer and a small glass of wine each day.
Don't smoke
Smoking harms the circulation of blood around, particularly blood vessels in the brain. The earlier you stop smoking, the more brain damage you'll avoid.
Manage long-term health conditions
Certain health conditions, such as high blood pressure, high cholesterol and diabetes can increase the risk of getting dementia. Going for a health check to see if you have any of these is advised. Eating well and regularly exercising can help prevent and manage these conditions.
Protect your eyesight and hearing
Uncorrected vision loss can increase the risk of dementia. Similarly, hearing loss is tied to increased risk of dementia and could be an early symptom. The use of hearing aids has been shown to reduce the risk of dementia to the level of a person with normal hearing.
Protect your head
Traumatic brain injuries caused by a blow or jolt to the head, particularly when a person is knocked unconscious, can start a process in the brain where the substances that cause Alzheimer's disease build up around the injured area. If you're in a situation where there's higher-than-normal risk of head injury, such as riding a bike or playing cricket, make sure to wear protective headgear.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
20 minutes ago
- The Independent
Southern China hit by outbreak of mosquito-borne infection chikungunya
China is experiencing an outbreak of chikungunya, a mosquito-borne infection, with thousands of cases reported in the south. Chikungunya fever cases jumped to 4,014 on Friday, representing a rapid rise in numbers since authorities started tracking cases two weeks ago, according to public records released by health departments in districts in Foshan. The city in China's southern province Guangdong has been heavily impacted by the surge in infections. The chikungunya outbreak remains 'quite severe,' Sun Yang, deputy director of the National Center for Disease Control and Prevention, said at a news conference on Wednesday in Foshan. Chikungunya is spread to people by the bites of infected mosquitoes. It causes fever and severe joint pain, but deaths are rare, according to the World Health Organization. The Chinese Center for Disease Control and Prevention has issued various advisories on how to prevent chikungunya fever and dengue fever, a similar disease also spread by mosquitoes. Physical protection barriers, such as screen doors, mosquito nets for beds and mosquito repellent on exposed skin, was recommended. It said that the epidemic was 'imported' without specifying from where. The Chinese agency also called for people who have symptoms like fever, rash and joint pain to see a doctor. Shunde district in Foshan, where 90% of the cases are located, is famous for its Cantonese food, and sees many visitors each year. Patients who tested positive for chikungunya fever stayed in hospital beds covered by mosquito nets, according to photos shown on state-run broadcaster CCTV. Local media reports said on Thursday that local authorities had almost doubled the number of mosquito-proof isolation beds to 7,220 to meet the growing demand. Authorities in Guangdong are urging residents to make sure there's no standing water in their homes, such as in flowerpots, coffee machines or spare bottles. The Health Commission in Foshan stated on Thursday that a fine of up to 10,000 yuan ($1,400) could be applied if violations are found. The Beijing CDC said on Tuesday that the city occasionally experiences imported cases of chikungunya fever. There are two chikungunya vaccines that have received regulatory approvals in several countries and/or have been recommended for use in populations at risk, but the vaccines are neither widely available nor in widespread use, according to WHO. China had its first chikungunya spike in 2010 with 253 cases in Dongguan, a nearby city in the same province, according to the Guangdong provincial CDC. Several cases were found in years since then, but they weren't widespread. The country's first case was imported in 1987, according to research papers and media reports.
Telegraph
an hour ago
- Telegraph
Covid vaccines ‘saved far fewer lives than first thought'
Covid vaccines saved far fewer lives than first thought, a major new analysis has concluded, with researchers criticising 'aggressive mandates'. In 2024, the World Health Organisation (WHO) claimed that jabs prevented the deaths of 14.4 million globally in the first year alone, with some estimates putting the figure closer to 20 million. However, new modelling by Stanford University and Italian researchers suggests that while the vaccine did undoubtedly save lives, the true figure is 'substantially more conservative' and closer to 2.5 million worldwide over the course of the entire pandemic. The team estimated that nine of 10 prevented deaths were in the over-60s, with jabs saving just 299 youngsters aged under 20, and 1,808 people aged between 20 and 30 globally. Overall 5,400 people needed to be vaccinated to save one life but in the under-30s this figure rose to 100,000 jabs, the paper suggests. Researchers criticised 'aggressive mandates and the zealotry to vaccinate everyone at all cost', adding that the findings had implications for how future vaccine rollouts are handled. John Ioannidis, Professor of Medicine at Stanford University and the first author, said: 'I think early estimates were based on many parameters having values that are incompatible with our current understanding. 'In principle, targeting the populations who would get the vast majority of the benefit and letting alone those with questionable risk-benefit and cost-benefit makes a lot of sense. 'Aggressive mandates and the zealotry to vaccinate everyone at all cost were probably a bad idea.' Since 2021, more than 13 billion Covid-19 vaccine doses have been administered. But there have been mounting concerns that vaccines could be harmful for some people, particularly the young, and that the risk was not worth the benefit for a population at little risk from Covid. More than 17,500 Britons have applied to the Government's vaccine damage payment scheme believing they or loved ones were injured by the jab. In June, manufacturers added warnings for myocarditis and pericarditis to Covid-19 messenger RNA (mRNA) vaccines' prescribing information. For the new study, experts used worldwide population data, alongside vaccine effectiveness and infection fatality rates, to estimate how many people died from a Covid infection before or after the periods of vaccination. The team believes earlier modelling may have used overly pessimistic infection fatality rates and overly optimistic vaccine effectiveness, while failing to consider how quickly protection waned. Based on fewer assumptions Earlier studies may also have underestimated how many people had already been unknowingly infected by the time they had the vaccine. Dr Angelo Maria Pezzullo, researcher in general and applied hygiene at the Catholic University of the Sacred Heart, in Milan, said: 'Before ours, several studies tried to estimate lives saved by vaccines with different models and in different periods or parts of the world, but this one is the most comprehensive because it is based on worldwide data. it also covers the omicron period. 'It also calculates the number of years of life that was saved, and it is based on fewer assumptions about the pandemic trend.' The team calculated that around 14.8 million life-years were saved, one life-year saved per 900 vaccine doses administered. Researchers concluded that although vaccines had a 'substantial benefit' on global mortality, it was 'mostly limited' to older people. The over-70s made up nearly 70 per cent of the lives saved, while the 60 to 70s accounted for a further 20 per cent. In contrast, under-20s made up just 0.01 per cent of lives saved and 20 to 30s were 0.07 per cent. Professor Stefania Boccia, of the Catholic University of the Sacred Heart, added: 'These estimates are substantially more conservative than previous calculations that focused mainly on the first year of vaccination, but clearly demonstrate an important overall benefit from Covid-19 vaccination over the period 2020-2024. 'Most of the benefits, in terms of lives and life-years saved, have been secured for a portion of the global population who is typically more fragile, the elderly.' Sir David Davis, the former Brexit secretary who fought against vaccine mandates, said: 'Frankly it's a good cautionary tale that if we have another pandemic we should be far more clinical about the risk-benefit ratio. 'We knew pretty quickly who the most susceptible groups were and we should have focused very strictly on them, rather than placing people who were at little risk in hazard's way. 'The level of aggression of trying to force people to become vaccinated and shutting down people who were raising concerns, the reasons for those concerns are all validated in this report.'
Daily Mail
2 hours ago
- Daily Mail
Doctors invent at-home test for condition that affects millions of Americans but goes undiagnosed for up to 10 YEARS
A first-of-its-kind at-home test can reveal whether a person suffers from endometriosis, a condition that leaves patients suffering from debilitating pain and without a diagnosis for up to a decade. Endometriosis is a condition that causes tissue similar to the lining of the uterus, or endometrium, to grow outside the uterus. It affects at least 11 percent of American women, more than 6.5 million. This tissue thickens and breaks down, but because it grows outside the uterus, there is no way for it to the leave body like typical lining does in blood during menstruation. It becomes trapped and leads to the formation of cysts. It often causes damage to the ovaries, fallopian tubes and the tissue lining the pelvis and can cause extreme menstrual pain, pain during sex, excessive bleeding, fatigue, diarrhea, constipation and fertility problems. Typically, it takes about a decade for doctors to diagnose endometriosis because of misdiagnosis, stigma and lack of access to proper healthcare - which can leave many women in excruciating pain for years. In many cases, doctors conduct a laparoscopy to diagnose endometriosis, which involves inserting a small camera in the body to find the extra tissue near the pelvis, taking a sample and testing it for confirmation. Once a diagnosis is made, potential treatments include birth control pills to stop the menstrual cycle or hormonal medication. As of now, there is no long-term treatment or cure for endometriosis. However, researchers at the Pennsylvania State University have now developed a new minimally invasive test patients can do themselves that can detect a biomarker for the disease in period blood and get a diagnosis - and start treatment - years earlier. Developed by Dr Dipanjan Pan, a Dorothy Foehr Huck & J. Lloyd Huck Chair Professor in Nanomedicine at the university, and his team, the at-home test offers up a diagnosis with nearly five times more accuracy than a laparoscopy in just 10 minutes. Dr Pan explained to Newsweek: 'This is the first time we have a proof of principle pregnancy-like test that shows one can collect menstrual blood and run it in the privacy of home and obtain the results in 10 minutes.' He noted that menstrual blood and tissue that is shed from the uterus each month is often overlooked as medical waste but could help with earlier and more accessible endometriosis detection. The team's prototype device can detect HMGB1 - a protein involved in endometriosis development and progression - in period blood with 500 percent more accuracy and confirm whether a person is suffering from the condition, he explained. To conduct the test, a sample of blood needs to be added to what looks like a Covid testing strip. If any HMGB1 proteins are present, they bind to the antibodies in the blood and when tested, turn two stripes dark - giving a positive result for endometriosis. In case of a negative result, only one stripe on the test darkens. Dr Pan told Newsweek: 'Currently, the only definitive [diagnostic] method is laparoscopic surgery [keyhole surgery, often invasive]. 'While menstrual blood is not yet a standard diagnostic tool for endometriosis, it's an active area of research with the potential to revolutionize how the condition is diagnosed and monitored in the future. 'With our technology, we are hoping to democratize women's health by providing a much-needed tool to track the onset or progression of this disease at the convenience and privacy of home. 'We anticipate that combining this technology with clinical symptoms will allow for early detection or diagnosis of endometriosis in adolescents and women.' Additionally, he also noted that the new test can help reduce the costs and time involved in scheduling and conducting a laparoscopy. He added: 'A recent study found that the average cost for a woman with endometriosis was around $30,000 per year. 'This huge financial burden can be reduced [as well as the shame and isolation from stigma] if an accurate at-home test becomes available. 'Our technology once developed, can reduce the time of diagnosis dramatically from years to minutes. 'Technologies are being developed that claim to be 'at-home' tests for endometriosis, but in fact they are developing ways to collect samples for laboratories to test.' Dr Pan also noted that with further testing and funding, he and his team intend to make the test accessible to people of all incomes. Furthermore, he also hopes to integrate the tests into period pads, making it possible to discreetly and conveniently monitor HMGB1 levels this way at home too. He said: 'It is our goal to [eventually] provide the kits directly to the public, at a reasonable price point, so women can do the test at home and share the results with their doctors, who will offer diagnoses and advice about next steps. 'We are looking at a couple of years of effort at this point. The team is actively looking for funding and partners to further develop the test. With funding, this timeline can be reduced in my opinion. '
